EUVIMEDEUVIMED entdecken
Crossref

Biomimetic Molybdenum Sulfide‐Catalyzed Tumor Ferroptosis and Bioimaging

Yan Xu, Weitao Yang, Yi Han, Kexin Bian, Weiwei Zeng, Liangwen Hao, Hui Wang, Yingsheng Cheng, Peijun Wang, Bingbo Zhang iD

Small · 2023

DOI: 10.1002/smll.202207544 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2023. Verfasst von Yan Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Tongji Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, The Institute for Biomedical Engineering & Nan…. Hauptthemen laut MEDLINE: Ferroptosis, Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Program of Shanghai Academic Research Leader, Natural Science Foundation of Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The chemical generation of singlet oxygen ( 1 O 2 ) by the MoO 4 2− ‐catalyzed disproportionation of hydrogen peroxide (H 2 O 2 ) has been widely applied in numerous catalytic processes; however, such molybdate ions cannot be administered for redox‐based cancer therapeutics. This work reports the albumin‐mediated biomimetic synthesis of highly active molybdenum sulfide (denoted MoB) nanocatalysts that mediate the simultaneous generation of 1 O 2 and superoxide anion (O 2 •− ) from H 2 O 2 , which is relatively abundant in malignant tumors. The MoB‐catalyzed reactive oxygen species (ROS) are able to activate the ferroptosis pathway and cause lipid peroxidation for efficient cancer therapy. Furthermore, for the first time, the catalytic activity of MoB is visualized in situ. Moreover, a catalytic imaging modality based on MoB is developed for specific imaging of inflammation diseases without background interference. Therefore, this study presents a biomimetic strategy toward Mo‐based nanocatalysts for ROS‐facilitated tumor ferroptosis and catalytic imaging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisNeoplasmsHumansBiomimeticsCatalysisCell Line, TumorHydrogen PeroxideReactive Oxygen SpeciesAnionsDisulfidesMolybdenum

Stichwörter der Autor:innen

biomimetic synthesiscatalytic imagingferroptosisnanocatalysts

Substanzen

Hydrogen PeroxideReactive Oxygen SpeciesAnionsmolybdenum disulfideDisulfidesMolybdenum

Autor:innen und Institutionen

  • Department of Radiology, Tongji Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, The Institute for Biomedical Engineering & Nano Science, School of Medicine, Tongji University, Shanghai, 200065, Ch…
  • Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, China.

ORCID-Profile: Bingbo Zhang

Förderung

  • National Natural Science Foundation of China
  • Program of Shanghai Academic Research Leader
  • Natural Science Foundation of Shanghai
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Xu, Y., Yang, W., Han, Y., Bian, K., Zeng, W., Hao, L., Wang, H., Cheng, Y., Wang, P., & Zhang, B. (2023). Biomimetic Molybdenum Sulfide‐Catalyzed Tumor Ferroptosis and Bioimaging. Small. https://doi.org/10.1002/smll.202207544

Vancouver

Xu Y, Yang W, Han Y, Bian K, Zeng W, Hao L, et al. Biomimetic Molybdenum Sulfide‐Catalyzed Tumor Ferroptosis and Bioimaging. Small. 2023. doi:10.1002/smll.202207544

BibTeX
@article{Xu2023,
  author = {Xu, Yan and Yang, Weitao and Han, Yi and Bian, Kexin and Zeng, Weiwei and Hao, Liangwen and Wang, Hui and Cheng, Yingsheng and Wang, Peijun and Zhang, Bingbo},
  title = {Biomimetic Molybdenum Sulfide‐Catalyzed Tumor Ferroptosis and Bioimaging},
  journal = {Small},
  year = {2023},
  doi = {10.1002/smll.202207544}
}
Kostenlos starten →